July 20 (Reuters) - Japan's Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced plans to build a dedicated distributor network to support commercialization of its peptide portfolio across ...

QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts ...

New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, ...

Recent rains in Central Texas have spiked mosquito activity, with one Austin trap testing positive for West Nile virus, ...

NEW DELHI, July 21, 2026 /PRNewswire/ -- Takeda today announced that India's Drug Controller General of India (DCGI) has granted marketing authorization for Takeda's dengue vaccine (TAK-003) for the ...

Recent rains in Central Texas have spiked mosquito activity, with one Austin trap testing positive for West Nile virus, ...

The approval comes at a critical time for public health, as reported dengue cases in India have increased 11-fold in the past two decades[1]Takeda's dengue vaccine (TAK-003) is the most extensively ...

QDENGA, the first dengue vaccine approved in India, is used for the prevention of dengue in individuals aged 4-60 years. It ...

SK pharmteco today announced details of its ongoing strategic manufacturing partnership with Genethon, a France-based pioneering nonprofit research and development organization dedicated to gene ...

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved ...